Aristopharma Ltd. is one of the Top 10 pharmaceutical companies in Bangladesh. The company started its journey in 1986 with the honest promise to provide quality medicines at affordable prices to the countrymen. Its state-of-the-art manufacturing plant, located at Shampur-Kadamtali I/A, 10 km from central Dhaka, is equipped with highly sophisticated and advanced facilities. The facility is planned and designed to meet the local as well as international demand both qualitatively and quantitatively. Aristopharma manufactures medicines of wide range of therapeutic classes like antiulcerants, antibiotics, NSAIDs, antipyretics, vitamins & minerals, laxatives, cardiovasculars, antidiabetics, steroids, antispasmodics, antihistamines, antipsychotics, antiemetics, antiseptics and many more. It started manufacturing sterile ophthalmic products in 2002 and presently is maintaining no. 1 position in ophthalmic market in Bangladesh. In 2010 Aristopharma expanded its plant & started manufacturing hi-tech products like inhalers, lyophilized injections, pre-filled syringes, suppositories, insulin & other bio-tech products. Recently Aristopharma has opened its new UK MHRA standard plant at Gachha, Gazipur with dedicated facility for cephalosporin products. Construction work of dedicated Ophthalmic & Oncology plants are also running in full swing in this new campus.
In Aristopharma, quality is a journey, not a goal. It continuously sets higher standards and feels passionate to achieve that. The motto of Aristopharma's quality policy is “Quality – the unit we count” and by quality we don’t mean only product quality rather it is infused in every activities that we do.
Aristopharma conducted bioequivalence study for its products like Omep (Omeprazole) Capsule, Metacard MR (Trimetazidine) Tablet, Lodipin-5 (Amlodipine) Tablet, AZ (Azithromycin) Capsule & Suspension, Aropen (Meropenem) Injection etc. The company also conducted clinical trials on Taxetil (Cefpodoxime), Afix (Cefixime), Metacard MR (Trimetazidine), Ipec-Plus (Iron Polymaltose+Zinc+Folic Acid) etc. and the results of these studies showed that they are as effective as innovators' brands. It may be mentioned that clinical trials on some other products are ongoing at different hospitals and universities.
With the aim to cope with the challenges of globalization, Aristopharma ltd. stepped beyond the boundary of Bangladesh in 2000, Vietnam being the first country to export. Today Aristopharma exports it quality medicines to 34 countries of 5 continents and is moving aggressively to expand and extend its export market.
As a recognition to its Quality Management System, Aristopharma achieved ISO 9001:2000 certificate in 2005. The certificate was issued by Orion Registrar Inc. USA, one of the prime certification bodies in the world. Later on the certificate was upgraded to ISO 9001:2008 standard.
Today around 5000 employees are relentlessly working for Aristopharma in its journey to build a healthier future.
With the robust product range of around 200 brands in 400 dosage forms Aristopharma is focusing to be a major player in the branded generic market of this region.